Concepedia

Scott S. Billecke

SS

Statistics

Publications

20

Citations

2.9K

H-Index

19

Active since

1998

Affiliations

University of Michigan(Current)

The University of Texas Southwestern Medical Center

Michigan Medicine

Rappaport Family Institute for Research in the Medical Sciences

Beaumont Hospital, Royal Oak

Scott S. Billecke is an author at University of Michigan specializing in life sciences, biochemistry, and enzymology.

Publications per year

1998–2012

20

Publications

20

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

Michael Aviram, Mira Rosenblat, Scott S. Billecke et al. · Free Radical Biology and Medicine · 1999 · 600 citations

, , +7

Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities

Michael Aviram, Scott S. Billecke, Robert C. Sorenson et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1998 · 454 citations · Full text

, , +15

Human Serum Paraoxonase (pon1) Isozymes Q and R Hydrolyze Lactones and Cyclic Carbonate Esters

Scott S. Billecke, Dragomir Draganov, Raymond E. Counsell et al. · Drug Metabolism and Disposition · 2000 · 400 citations

, , +11

Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation

Dragomir Draganov, Philip L. Stetson, Catherine E. Watson et al. · Journal of Biological Chemistry · 2000 · 336 citations · Full text

, , +8

Human Serum Paraoxonase/Arylesterase’s Retained Hydrophobic<i>N</i>-Terminal Leader Sequence Associates With HDLs by Binding Phospholipids

Robert C. Sorenson, Charles L. Bisgaier, Cary Hsu et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 326 citations · Full text

, , +14

1–5 of 20